CARL ZEISS VISION INTERNATIONAL GMBH

Their core work

Carl Zeiss Vision International is the vision care division of the ZEISS Group, one of the world's leading optics and optoelectronics companies. They develop precision ophthalmic lenses, vision correction technologies, and optical measurement systems. In H2020, they contribute industry expertise in visual perception science, eye tracking, and optics to academic-led research consortia — bridging the gap between fundamental vision research and commercial lens/device development. Their recent involvement in AI-driven brain-computer interfaces signals expansion beyond traditional optics into intelligent vision systems.

What they specialise in

How they've shifted over time

Carl Zeiss Vision's H2020 trajectory shows a clear pivot from classical optics research toward intelligent, AI-augmented systems. Their early projects (2016-2019) focused squarely on core vision science — understanding myopia and visual perception mechanisms. By 2021, they joined MAIA, a project centered on brain-derived control, neural networks, and AI-human interaction — a significant departure from pure optics into cognitive technology and assistive devices.

Moving from understanding how humans see toward building AI systems that interpret and respond to human visual and neural signals — positioning themselves at the intersection of optics and intelligent assistive technology.

How they like to work

Carl Zeiss Vision participates exclusively as a partner, never leading consortia — consistent with a large industrial company contributing domain expertise and real-world application context to academic-driven research. Across just 3 projects they have worked with 21 unique partners in 8 countries, indicating they join diverse, broad consortia rather than forming tight recurring partnerships. This suggests they are valued as an industry anchor that provides commercial grounding and access to optical technology platforms.

They have collaborated with 21 unique partners across 8 countries, indicating a wide European network despite limited project count. Their participation in both Marie Curie mobility actions and research-innovation actions connects them to both training networks and applied research consortia.

What sets them apart

Carl Zeiss Vision brings something rare to EU consortia: deep industrial capability in precision optics combined with genuine research engagement in visual neuroscience. Unlike pure research partners, they can translate findings into commercial vision products with global market reach. For consortium builders, they offer credibility, industry validation, and a pathway from lab results to real-world optical and vision-care applications.

Highlights from their portfolio

• MAIA
  Represents a strategic leap from optics into AI and brain-computer interfaces — their largest recent investment (EUR 403K) and a signal of future direction.
• MyFUN
  Their highest-funded project (EUR 498K) directly aligned with core business in ophthalmic lenses and myopia correction.
• PLATYPUS
  Marie Curie mobility action connecting vision science labs across Europe — positions Zeiss within the academic eye-tracking and perception research community.